OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech CARE Q1 2026 Earnings EPS Misses Estimates by Over 85 as Stock Rises Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline SII Q1 2026 Earnings EPS Surprises Upward Despite Broader Market Headwinds BPOP Q1 2026 Earnings Earnings Surpass Estimates on Solid Core Performance CNMD Q1 2026 Earnings EPS Surprise Fails to Lift Stock as Revenue Picture Stays Cloudy